发明名称 |
Methods of treating patients suffering from movement disorders |
摘要 |
The present invention is directed to methods of treating movement disorders by administering an effective amount of one or more adenosine A2A receptor antagonists to a patient in need thereof. The present invention also provides methods of decreasing the adverse effects of L-DOPA in patients receiving L-DOPA therapy in the treatment of Parkinson's disease. The present invention further provides methods and compositions for treating Parkinson's disease patients with sub-clinically effective doses of L-DOPA by combining L-DOPA treatment with an effective amount of one or more adenosine A2A receptor antagonists (i.e., L-DOPA sparing effect). The present invention further provides methods of effective treatment of Parkinson's disease by co-administering at least one adenosine A2A receptor antagonist, L-DOPA and a dopamine agonist and/or a COMT inhibitor and/or a MAO inhibitor. The present invention further provides methods of prolonging effective treatment of Parkinson's disease by administering an adenosine A2A receptor antagonist singly or together with a dopamine agonist, and/or a COMT inhibitor, and/or a MAO inhibitor without prior or subsequent administration of L-DOPA, delaying or removing on-set of L-DOPA motor complication.
|
申请公布号 |
US2004198753(A1) |
申请公布日期 |
2004.10.07 |
申请号 |
US20030353240 |
申请日期 |
2003.01.28 |
申请人 |
KASE HIROSHI;MORI AKIHISA;WAKI YUTAKA;OHSAWA YUTAKA;KARASAWA AKIRA;KUWANA YOSHIHISA |
发明人 |
KASE HIROSHI;MORI AKIHISA;WAKI YUTAKA;OHSAWA YUTAKA;KARASAWA AKIRA;KUWANA YOSHIHISA |
分类号 |
C07D473/06;A61K31/522;A61K45/00;A61P25/14;A61P25/16;(IPC1-7):A61K31/522 |
主分类号 |
C07D473/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|